Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres. [electronic resource] by
- Sanganalmath, P
- Lester, J E
- Bradshaw, A G
- Das, T
- Esler, C
- Roy, A E F
- Toy, E
- Lester, J F
- Button, M
- Wilson, P
- Comins, C
- Atherton, P
- Pickles, R
- Foweraker, K
- Walker, G A
- Keni, M
- Hatton, M Q
Producer: 20190408
In:
Clinical oncology (Royal College of Radiologists (Great Britain)) vol. 30
Availability: No items available.
|
|
16.
|
Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: the United Kingdom Named Patient Programme. [electronic resource] by
- Khan, F
- Ottensmeier, C
- Popat, S
- Dua, D
- Dorey, N
- Ellis, S
- Szabo, M
- Upadhyay, S
- Califano, R
- Chan, S
- Lee, L
- Ali, C W
- Nicolson, M
- Bates, A T
- Button, M
- Chaudhuri, A
- Mulvenna, P
- Shaw, H M
- Danson, S J
Producer: 20140718
In:
European journal of cancer (Oxford, England : 1990) vol. 50
Availability: No items available.
|